ask="3.32"
ask_size="500"
average_daily_volume="3915330"
bid="3.00"
bid_size="500"
book_value="-1.75"
change="+0.11"
change_from_200_day_moving_average="-1.70"
change_from_50_day_moving_average="-0.20"
change_from_52_week_high="-5.79"
change_From_52_week_low="0.40"
change_in_percent="+3.36%"
close="3.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="122599000"
high="3.25"
high_52_weeks="9.02"
last_trade_date="2/9/2017"
last_trade_price="3.23"
last_trade_size="48514"
last_trade_time="4:00pm"
low="3.13"
low_52_weeks="2.83"
market_capitalization="418.66M"
moving_average_200_day="4.93"
moving_average_50_day="3.43"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.13"
pe_ratio="N/A"
peg_ratio="-0.47"
percent_change_from_200_day_moving_average="-34.47%"
percent_change_from_50_day_moving_average="-5.81%"
percent_change_from_52_week_high="-64.17%"
percent_change_from_52_week_low="+14.13%"
previous_close="3.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.88"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="5.39"
stock_exchange="NGM"
symbol="MACK"
volume="1020280"
weeks_range_52="2.83 - 9.02"
